<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04162054</url>
  </required_header>
  <id_info>
    <org_study_id>003</org_study_id>
    <nct_id>NCT04162054</nct_id>
  </id_info>
  <brief_title>Observation of Acute Cardiopulmonary Effects in Healthy Individuals Performing Cardiopulmonary Exercise Test (CPX) During Whole Body Vibration (WBV)</brief_title>
  <acronym>GALILEOhealthy</acronym>
  <official_title>Observation of Acute Cardiopulmonary Effects in Healthy Individuals Performing Cardiopulmonary Exercise Test (CPX) During Whole Body Vibration (WBV)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum der Universität Köln</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum der Universität Köln</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study to evaluate acute cardiopulmonary effects of oscillatory whole body
      vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test
      (CPX).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oscillatory whole-body vibration (WBV) is a novel exercise modality, which is performed on a
      vibrating platform that moves in sinusoidal oscillations, and during which static and dynamic
      exercises can be performed. Rapid movements of the platform lead to muscle spindle reﬂexes,
      which result in reﬂectory contraction of muscle groups and thus promote gain of muscle
      strength and power. The most efﬁcient vibration rate enhancing muscle function is assumed to
      be ∼20 Hz, leading to constant muscle contraction and anaerobic metabolism of the affected
      muscle ﬁbres. As a consequence, lactate liberation serves as a stimulus for muscle gain.This
      methodology has been successfully utilised to enhance moving velocity, muscle power and
      strength in young athletes and chronic obstructive pulmonary disease though not been
      understood in all details. Therefore this investigation will help to evaluate acute
      cardiopulmonary effects of whole body vibration (WBV) on healthy individuals analysed in
      non-invasive cardiopulmonary exercise test (CPX).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peak VO2 in mililiter</measure>
    <time_frame>one day</time_frame>
    <description>maximal Oxygen saturation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nadir Co2 at anaerobic threshold</measure>
    <time_frame>one day</time_frame>
    <description>Nadir Co2 in mmHG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anaerobic threshold (AT)</measure>
    <time_frame>one day</time_frame>
    <description>AT in mililiter</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Acute Cardiopulmonary Effects</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational study to evaluate acute cardiopulmonary effects of whole body vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test (CPX).</intervention_name>
    <description>Observational study to evaluate acute cardiopulmonary effects of whole body vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test (CPX).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  healthy individuals planning on performing a WBV-Training

          -  healthy individuals planning on performing a CPX
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals planning on performing a WBV-Training

          -  healthy individuals planning on performing a CPX

        Exclusion Criteria:

          -  exclusion to perform CPX

          -  exclusion to perform WBV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Felix Gerhardt, MD</last_name>
    <phone>+4922147889413</phone>
    <email>felix.gerhardt@uk-koeln.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Spezialambulanz für pulmonale Hypertonie Uniklinik Köln</name>
      <address>
        <city>Köln</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Gerhardt F, Dumitrescu D, Gärtner C, Beccard R, Viethen T, Kramer T, Baldus S, Hellmich M, Schönau E, Rosenkranz S. Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study. Heart. 2017 Apr;103(8):592-598. doi: 10.1136/heartjnl-2016-309852. Epub 2017 Jan 18.</citation>
    <PMID>28100544</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>April 25, 2019</study_first_submitted>
  <study_first_submitted_qc>November 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2019</study_first_posted>
  <last_update_submitted>January 20, 2020</last_update_submitted>
  <last_update_submitted_qc>January 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum der Universität Köln</investigator_affiliation>
    <investigator_full_name>Felix Gerhardt</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

